Who owns Orexigen Therapeutics?

Key details on Orexigen Therapeutics (Ticker: OREX)

Who owns Orexigen Therapeutics?

Is OREX a good stock to own? Find out who bought Orexigen Therapeutics, who sold Orexigen Therapeutics (OREX) stock, and who holds a large position in Orexigen Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 10.13M $43.16M Sept. 30, 2014
T. Rowe Price Associates 6.67M $40.39M Dec. 31, 2014
Capital Research Global Investors^ 5.92M $35.90M Dec. 31, 2014
Samlyn Capital 5.69M $34.49M Dec. 31, 2014
BlackRock Fund Advisors 4.87M $29.49M Dec. 31, 2014
STATE STREET CORPORATION 4.73M $28.66M Dec. 31, 2014
S.A.C. Capital Advisors 4.30M $24.20M Dec. 31, 2013
Foresite Capital Management II 4.20M $32.89M March 31, 2015
NEA Management Company 3.71M $22.48M Dec. 31, 2014
Vanguard 3.67M $22.22M Dec. 31, 2014
Franklin Resources 3.58M $21.67M Dec. 31, 2014
Partner Fund Management 3.18M $19.27M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 3.18M $19.26M Dec. 31, 2014
FIRST MANHATTAN 2.81M $17.37M June 30, 2014
Farallon Capital Management 2.68M $17.45M March 31, 2014
Deutsche Bank Aktiengesellschaft 2.55M $14.66M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 2.53M $10.77M Sept. 30, 2014
Millennium Management 2.36M $15.33M March 31, 2014
MORGAN STANLEY 2.31M $14.01M Dec. 31, 2014
RS INVESTMENT MANAGEMENT 2.23M $9.50M Sept. 30, 2014
FIL 2.21M $14.34M March 31, 2014
Meditor 2.10M $12.87M Sept. 30, 2013
QVT Financial 1.99M $7.35M March 31, 2012
Palo Alto Investors 1.93M $11.70M Dec. 31, 2014
Lamond Capital Partners 1.89M $11.46M Dec. 31, 2014
Bank of America Corporation 1.87M $11.19M Dec. 31, 2014
FRED ALGER MANAGEMENT 1.78M $11.57M March 31, 2014
CQS Cayman Limited Partnership 1.75M $10.61M Dec. 31, 2014
COLUMBIA PARTNERS L L C INVESTMENT MANAGEMENT 1.70M $7.24M Sept. 30, 2014
Rock Springs Capital Management 1.69M $10.21M Dec. 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.68M $13.15M March 31, 2015
Visium Asset Management 1.67M $9.77M June 30, 2013
Credit Suisse AG 1.55M $6.61M Sept. 30, 2014
D. E. Shaw & Co 1.55M $8.72M Dec. 31, 2013
NORTHERN TRUST 1.51M $8.50M Dec. 31, 2013

Who sold Orexigen Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Daniel D. Thurber Dec. 31, 2010 1.95M $15.79M